|
Medicare
- House Tri-Committee Health Reform Discussion Draft
July 8, 2009
pdf
Preliminary analysis of the Medicare component of the health reform discussion draft posted on the Web site of the House Committee on Education and Labor on June 19, 2009
- An Assessment of the Potential Effects of the Reductions in Medicare's Payment Rates for Physicians Called for Under Current Law
March 27, 2009
pdf
Letter to the Honorable John M. Spratt Jr.
- Key Issues in Analyzing Major Health Insurance Proposals
December 2008
pdf charts blog
- Budget Options, Volume 1: Health Care
December 2008
pdf charts blog
- The Long-Term Budgetary Effects of Three Specified Policy Scenarios
March 14, 2008
html pdf blog
Letter to the Honorable John M. Spratt Jr.
- Estimated Changes in Net Federal Outlays from Alternative Proposals for Changing Physician Payment Rates
March 2008
pdf
- Additional Information on Medicare Advantage Provisions of the CHAMP Act
October 10, 2007
pdf
Letter to the Honorable Jim McCrery
- Estimate of the Budgetary Impact of Section 651 of H.R. 3162, the Children's Health and Medicare Protection Act of 2007
August 17, 2007
pdf
Letter to the Honorable Sam Johnson
- Information on Bids by Medicare Advantage Plans
August 17, 2007
pdf
Letter to the Honorable John M. Spratt Jr.
- Background Paper: The Impact of Medicare's Payment Rates on the Volume of Services Provided by Skilled Nursing Facilities
July 2007
pdf
- Testimony on the Medicare Advantage Program
June 28, 2007
html pdf webcast
Testimony before the Committee on the Budget, U.S. House of Representatives
- Medicare Advantage: Private Health Plans in Medicare
June 28, 2007
html pdf
- Testimony on Health Care and the Budget: Issues and Challenges for Reform
June 21, 2007
html pdf webcast
Testimony before the Committee on the Budget, United States Senate
- Testimony on Research on the Comparative Effectiveness of Medical Treatments: Options for an Expanded Federal Role
June 12, 2007
html pdf
Testimony before the Subcommittee on Health, Committee on Ways and Means, U.S. House of Representatives
- Background Paper: Factors Underlying the Growth in Medicare's Spending for Physicians' Services
June 2007
pdf
- S. 1082, Prescription Drug User Fee Amendments of 2007
April 27, 2007
pdf
Cost estimate for the bill as reported by the Senate Committee on Health, Education, Labor, and Pensions on April 24, 2007
- Medicare Advantage Statistics by State
April 17, 2007
pdf
Letter to the Honorable Ron Wyden
- Effects of Medicare's Drug Pricing on Other Purchasers
April 16, 2007
pdf
Letter to the Honorable Debbie Stabenow
- S. 3, Medicare Prescription Drug Price Negotiation Act of 2007
April 16, 2007
pdf
Cost estimate for the bill as reported by the Senate Committee on Finance on April 13, 2007
- Testimony on the Medicare Advantage Program: Enrollment Trends and Budgetary Effects
April 11, 2007
pdf webcast
Testimony before the Committee on Finance, United States Senate
- Issues Regarding Drug Price Negotiation in Medicare
April 10, 2007
pdf
Letter to the Honorable Ron Wyden
- Testimony on the Medicare Advantage Program: Trends and Options
March 21, 2007
html pdf
Testimony before the Subcommittee on Health, Committee on Ways and Means, U.S. House of Representatives
- Potential Effects of Disclosing Price Rebates on the Medicare Drug Benefit
March 12, 2007
pdf
Letter to the Honorable Joe Barton and the Honorable Jim McCrery
- Testimony on Medicare's Payments to Physicians: Options for Changing the Sustainable Growth Rate
March 1, 2007
pdf webcast
Testimony before the Committee on Finance, United States Senate
- Detailed Projections for Medicare, Medicaid, and State Children's Health Insurance Program
March 2007
pdf
- H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007
January 10, 2007
html pdf
Cost estimate for the bill as introduced on January 5, 2007.
- Designing a Premium Support System for Medicare
December 2006
pdf
- The Sustainable Growth Rate Formula for Setting Medicare's Physician Payment Rates
September 7, 2006
pdf
- Testimony on Medicare's Physician Payment Rates and the Sustainable Growth Rate
July 25, 2006
pdf
Testimony before the Subcommittee on Health, Committee on Energy and Commerce, U.S. House of Representatives
- Estimate of the Budgetary Impact of Extending the Initial Enrollment Period for the Medicare Prescription Drug Benefit (Part D of Medicare)
May 1, 2006
pdf
Letter to the Honorable Fortney Pete Stark
- The Long-Term Budget Outlook
December 2005
pdf data
- High-Cost Medicare Beneficiaries
May 2005
html pdf
- Table of Estimates of Proposals to Revise Medicare Payments for Physicians' Services
March 2005
pdf
- Updated Estimates of Spending for the Medicare Prescription Drug Program
March 4, 2005
html pdf
Letter to the Honorable Joe Barton
- Projection of Spending for the Medicare Part D Benefit
February 9, 2005
html pdf
Letter to the Honorable William "Bill" M. Thomas
- CBO's Analysis of Regional Preferred Provider Organizations Under the Medicare Modernization Act
October 2004
html pdf
- A Detailed Description of CBO's Cost Estimate for the Medicare Prescription Drug Benefit
July 2004
html pdf
- Testimony on Medicare's Physician Fee Schedule
May 5, 2004
html pdf
Testimony before the Subcommittee on Health, Committee on Energy and Commerce, U.S. House of Representatives
- Would Prescription Drug Importation Reduce U.S. Drug Spending?
April 29, 2004
html pdf
- Testimony on Estimating the Cost of the Medicare Modernization Act
March 24, 2004
html pdf
Testimony before the Committee on Ways and Means, U.S. House of Representatives
- Authority to Negotiate Prices for Single-Source Drugs for Medicare Beneficiaries
March 3, 2004
html pdf
Letter to the Honorable Ron Wyden
- Comparison of CBO and Administration Estimates of the Effect of H.R. 1 on Direct Spending
February 2, 2004
html pdf
Letter to the Honorable Jim Nussle
- Estimate of the Effect of Striking the "Noninterference" Provision as Added by P.L. 108-173, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
January 23, 2004
html pdf
Letter to the Honorable William H. Frist, M.D.
- Letter to the Honorable Ted Stevens regarding H.R. 1, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
November 20, 2003
html pdf
- H.R. 1, Medicare Prescription Drug, Improvement, and Modernization Act of 2003
November 20, 2003
html pdf
Cost estimate for the bill conference agreement
- Letter to the Honorable Don Nickles providing additional information about CBO's cost estimate for the conference agreement on H.R. 1
November 20, 2003
html pdf
- H.R. 2427, Pharmaceutical Market Access Act of 2003
November 19, 2003
html pdf
Cost estimate for the bill as passed by the U.S. House of Representatives on July 25, 2003
- Medicare Beneficiaries Who Receive Health Insurance Provided by Employers
November 14, 2003
html pdf
Letter to the Honorable William "Bill" M. Thomas
- Letter to the Honorable Orrin G. Hatch regarding S. 1, the Prescription Drug and Medicare Improvement Act of 2003
August 27, 2003
html pdf
- H.R. 1, Medicare Prescription Drug and Modernization Act of 2003
July 22, 2003
html pdf
Cost estimate for the bill as passed by the House of Representatives on June 27, 2003
- S. 1, Prescription Drug and Medicare Improvement Act of 2003
July 22, 2003
html pdf
Cost estimate for the bill as passed by the Senate on June 27, 2003, with a modification requested by Senate conferees
- H.R. 1, Medicare and Prescription Drug Moderization Act of 2003
June 26, 2003
html pdf
Cost estimate for the democratic amendment to H.R. 1.
- H.R. 1, Medicare Prescription Drug and Modernization Act of 2003
June 25, 2003
html pdf
Cost estimate for the bill as introduced by the Committee on Rules on June 25, 2003.
- S. 1, Prescription Drug and Medicare Improvement Act of 2003, as reported by the Committee on Finance, and incorporating subsequent changes provided by the committee on June 17, 2003
June 18, 2003
html pdf
Cost estimate for the bill as reported by the Committee on Finance, and incorporating subsequent changes provided by the committee on June 17, 2003
- S. 1, Prescription Drug and Medicare Improvement Act of 2003
June 17, 2003
html pdf
Cost estimate for the bill as reported by the Committee on Finance on June 13, 2003
- Testimony on Prescription Drug Coverage and Medicare's Fiscal Challenges
April 9, 2003
html pdf
Testimony before the Committee on Ways and Means, U.S. House of Representatives
- Testimony on the Medicare Challenge: It's Not Just About Prescription Drugs
March 20, 2003
html pdf
Testimony before the Special Committee on Aging, United States Senate
- Projected spending for prescription drugs by and on behalf of Medicare enrollees
February 3, 2003
html pdf
- Memo regarding projected spending for prescription drugs by and on behalf of Medicare enrollees
February 2003
html pdf
- Issues in Designing a Prescription Drug Benefit for Medicare
October 2002
html pdf
- Letter to the Honorable W. J. "Billy" Tauzin regarding H.R. 4954, the Medicare Modernization and Prescription Drug Act of 2002
September 24, 2002
html pdf
- Testimony on Disease Management in Medicare: Data Analysis and Benefit Design Issues
September 19, 2002
html pdf
Testimony before the Special Committee on Aging, United States Senate
- Letter to the Honorable William "Bill" M. Thomas regarding CBO's cost estimate for H.R. 4954, the Medicare Modernization and Prescription Drug Act of 2002
July 27, 2002
html pdf
- Preliminary cost estimate of S. 812 as Modified by the Edwards-Collins Amendment
July 2002
html pdf
- Medicare Modernization and Prescription Drug Act of 2002 (As Approved by the Energy and Commerce Committee)
June 24, 2002
html pdf
Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on June 21, 2002
- H.R. 4954, Medicare Modernization and Prescription Drug Act of 2002 (As Approved by the Ways and Means Committee)
June 24, 2002
html pdf
Cost estimate for the bill as ordered reported by the House Committee on Ways and Means on June 19, 2002
- Preliminary Cost Estimates of the Effects on Direct Spending of Establishing a Prescription Drug Benefit in Medicare
April 2002
pdf
- Testimony on Projections of Medicare and Prescription Drug Spending
March 7, 2002
html pdf
Testimony before the Committee on Finance, U.S. Senate
- S. 754, Drug Competition Act of 2001
February 1, 2002
html pdf
Cost estimate for the bill as ordered reported by the Senate Committee on the Judiciary on October 18, 2001
- Letter to the Honorable Michael Bilirakis regarding CBO's estimate of the costs of a prescription drug benefit in Medicare
August 10, 2001
html pdf
- Letter to the Honorable Max Baucus regarding updated estimates of the direct spending effects of four proposals from the 106th Congress for a prescription drug benefit in Medicare (Tables 1 and 5 corrected 08/10/2001)
June 11, 2001
html pdf
- Testimony on Medicare Reform: Providing Prescription Drug Coverage for Seniors
May 16, 2001
pdf
Testimony before the Committee on Energy and Commerce, Subcommittee on Health, U.S. House of Representatives
- Testimony on Laying the Groundwork for a Medicare Prescription Drug Benefit
March 27, 2001
html pdf
Testimony before the Committee on Ways and Means, Subcommittee on Health, U.S. House of Representatives
- Testimony on Prescription Drugs and Medicare Financing
March 22, 2001
html pdf
Testimony before the Committee on Finance, United States Senate
- Letter to the Honorable Frank R. Lautenberg regarding the assumptions underlying CBO's estimates of proposals for a Medicare prescription drug benefit
September 1, 2000
html pdf
- Testimony on a CBO Analysis of the Administration's Prescription Drug Proposal
May 11, 2000
html pdf
Testimony before the Subcommittee on Health, Committee on Ways and Means, U.S. House of Representatives
- How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry
July 1998
html pdf
- How the Medicaid Rebate on Prescription Drugs Affects Pricing in the Pharmaceutical Industry
January 1996
html pdf
|